

Rivian Automotive Inc (RIVN) gained 12.2% after strong Q2 production figures and raised delivery forecast. Other companies such as Nexa Resources SA (NEXA) and...
You can purchase shares of Vor Biopharma (NASDAQ:VOR) through any online brokerage.
Other companies in Vor Biopharma’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Vor Biopharma has a consensus price target of $61.67.
The stock price for Vor Biopharma (NASDAQ: VOR) is $20.5 last updated October 29, 2026 at 5:15 PM EDT.
There are no upcoming dividends for Vor Biopharma.
Vor Biopharma does not have any upcoming earnings scheduled.
There is no upcoming split for Vor Biopharma.
Vor Biopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to...